Loading insider details...
Latest Form 4 (Nov 2, 2026): Grant/Award of 2,750 TECH shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 2, 2026 | BIO-TECHNE Corp (TECH) | Grant/Award | 2,750 | n/a |
| Jun 5, 2026 | Keros Therapeutics, Inc. (KROS) | Grant/Award | 7,142 | n/a |
| Jun 5, 2026 | Keros Therapeutics, Inc. (KROS) | Sale | 2,625 | $28.1K |
| Nov 3, 2025 | BIO-TECHNE Corp (TECH) | Grant/Award | 1,640 | n/a |
| Jun 6, 2025 | Keros Therapeutics, Inc. (KROS) | Grant/Award | 5,250 | n/a |
| Oct 28, 2024 | BIO-TECHNE Corp (TECH) | Grant/Award | 1,462 | n/a |
| Jun 3, 2024 | Keros Therapeutics, Inc. (KROS) | Grant/Award | 10,000 | n/a |
| Oct 30, 2023 | BIO-TECHNE Corp (TECH) | Grant/Award | 1,625 | n/a |
| Jun 8, 2023 | Keros Therapeutics, Inc. (KROS) | Grant/Award | 10,000 | n/a |
| May 3, 2023 | Keros Therapeutics, Inc. (KROS) | Grant/Award | 20,000 | n/a |